Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for cystic fibrosis. A comparative study.

J E Dankert-Roelse, G J te Meerman, A Martijn

    Acta Paediatrica Scandinavica
    |March 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Optimization of performance of Dutch newborn screening for cystic fibrosis.

    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2023
    Same author

    Novel Algorithms for Improved Sensitivity in Non-Invasive Prenatal Testing.

    Scientific reports·2017
    Same author

    Parental knowledge reduces long term anxiety induced by false-positive test results after newborn screening for cystic fibrosis.

    Molecular genetics and metabolism reports·2016
    Same author

    Determining the genome-wide kinship coefficient seems unhelpful in distinguishing consanguineous couples with a high versus low risk for adverse reproductive outcome.

    BMC medical genetics·2015
    Same author

    Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data.

    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2014
    Same author

    Differences in clinical condition and genotype at time of diagnosis of cystic fibrosis by newborn screening or by symptoms.

    Molecular genetics and metabolism·2014

    Neonatal screening for cystic fibrosis (CF) using meconium albumin showed potential benefits. Early diagnosis and treatment appear to improve outcomes, but further research is needed to confirm the value of mass screening programs.

    Area of Science:

    • Pediatrics
    • Medical Screening
    • Genetic Disorders

    Background:

    • Neonatal screening programs aim for early detection of genetic disorders.
    • Cystic Fibrosis (CF) is a significant genetic disorder requiring timely intervention.
    • Previous screening methods for CF have varied in effectiveness.

    Purpose of the Study:

    • To evaluate the impact of early diagnosis and treatment on Cystic Fibrosis (CF) patient outcomes.
    • To compare outcomes between newborns screened for CF and those not screened.
    • To assess the feasibility and effectiveness of neonatal screening for CF via meconium albumin analysis.

    Main Methods:

    • A neonatal screening program for CF using meconium albumin determination was conducted in the Netherlands (1973-1979).

    Related Experiment Videos

  • Screening involved 94,043 newborns, with 116,953 serving as an unscreened control group.
  • A follow-up study initiated in 1980 compared CF patient outcomes in both screened and unscreened cohorts.

    • Main Results:

    • The study observed indications that very early diagnosis and treatment of CF positively influence patient outcomes.
    • Comparison of outcomes between the screened and unscreened groups suggested a benefit from early intervention.
    • Data analysis focused on long-term health status and survival rates in CF patients.

    Conclusions:

    • Very early diagnosis and treatment of Cystic Fibrosis (CF) show a beneficial effect on patient outcomes.
    • Further comprehensive studies are required to definitively determine the value of initiating mass neonatal screening for CF.
    • The findings support continued investigation into optimizing neonatal screening strategies for CF.